IMPROMUNE
Complementary food to optimize the immune response in dogs and cats
Nucleoforce is a specific nucleotide formula developed after studying the specific needs of different mammalian species. Nucleotides are semi-essential immunonutrients that, freely supplied orally, allow an optimal immune response in periods of immunosuppression. Nucleoforce promotes the phagocytic activity of macrophages, as well as the interaction of these with T cells. It also promotes the maturation, proliferation and activity of T lymphocytes. AHCC Vet is an extract of the mycelium of Lentinus edodes that promotes the activity of NK cells, as well as such as macrophage proliferation and T cell differentiation to Th1. Different studies have shown a synergistic effect of the combination of nucleoforce and AHCCVet by acting on the innate and adaptive response. This synergistic effect has been patented.
Pharmaceutical form:
Oral tablet.
Composition by tablet:
Nucleoforce 585mg; AHCC Vet 315mg; magnesium stearate.
Interactions and incompatibilities:
They have not been described.
Indications:
Dogs and Cats: Its use is recommended in immunocompromised dogs and cats such as:
Infectious processes: Bacteria (eg pyodermas), viruses (eg calicivirus, papillomatosis), parasites (eg demodicosis, giardia), fungi (eg ringworm, malasezzia), Leishmania .
Acquired immunosuppression: Administration of immunosuppressive drugs (eg glucocorticoids), immunosenescent geriatric animals.
Stress: Post-surgical stages/polytrauma (eg: caesarean section, pyometra), reproduction (eg: lactation, large litters), puppies (eg: perivaccinal period), malnutrition.
Contraindications and side effects:
They have not been described.
Route of administration:
Orally.
Administration:
For at least 20 days.
Leishmania: For a minimum of 6 months.
Special precautions:
They have not been described.
Conservation mode:
Store in cool, dry conditions

Special Formats

Shampoos
Necklaces
External
Internal
Internal and External



36 valuations Impromune 40 tablets | optimizes the immune response
Clear filtersNot yet reviewed